RxDoctor Payments Data

Roger Khouri, MD

Urology · Cleveland, OHNPI 1770014607

Payments from drug & device makers

What this record shows

This record is dominated by grants: $50,000 of the $56,556 with a category attached, or 88.4%. Boston Scientific accounts for 98.8% of it on its own, with 3 other manufacturers making up the rest. Reporting peaked in 2022 at $52,024 and has fallen 96.2% since, to $1,971 in 2025. Among urology clinicians in OH with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.

$56,556in general payments, 2019–2025

Across 92 payments — averaging $614.74 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Boston Scientific$56K
  • Coloplast$566
  • Boehringer Ingelheim$68
  • Medtronic$21

What the payments were for

  • Grants$50,00088%
  • Travel & lodging$3,3206%
  • Food & beverage$3,2366%

General payments by program year

22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

CompanyPaymentsTotal
Boston Scientific83$55,902
Coloplast7$566
Boehringer Ingelheim1$68
Medtronic1$21

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$56,556 in reported general payments places this provider in the 95th percentile of 485 urology providers in Ohio.

See all urology providers in Ohio

Medicare billing

Part B allowed, 2024
$83,771
Medicare patients
182
Services billed
718

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
MyrbetriqMirabegron31$24,471
PremarinEstrogens, Conjugated11$4,794
Tamsulosin Hcl96$1,279
Finasteride86$733
Cephalexin15$338
NitrofurantoinNitrofurantoin Macrocrystal16$221
Alfuzosin Hcl ErAlfuzosin Hcl21$117
Sulfamethoxazole-TrimethoprimSulfamethoxazole/Trimethoprim12$50

Paid to pharmacies, not to this prescriber.

Other urology in Cleveland

See the full list for Ohio

Where these figures come from

Is this you, or does something look wrong? →